Phylogenetic and phylodynamic approaches to understanding and combating the early SARS-CoV-2 pandemic
暂无分享,去创建一个
O. Pybus | D. Aanensen | S. Hill | S. Attwood | T. Connor
[1] O. Pybus,et al. Emergence and widespread circulation of a recombinant SARS-CoV-2 lineage in North America , 2021, Cell Host & Microbe.
[2] Julia A. Palacios,et al. Adaptive Preferential Sampling in Phylodynamics With an Application to SARS-CoV-2 , 2021, J. Comput. Graph. Stat..
[3] M. Clerici,et al. The substitution spectra of coronavirus genomes , 2021, Briefings Bioinform..
[4] M. Kraemer,et al. Progress and challenges in virus genomic epidemiology. , 2021, Trends in parasitology.
[5] R. Bouckaert,et al. Real-Time Genomics for Tracking Severe Acute Respiratory Syndrome Coronavirus 2 Border Incursions after Virus Elimination, New Zealand , 2021, Emerging infectious diseases.
[6] Nuno R. Faria,et al. Global disparities in SARS-CoV-2 genomic surveillance , 2021, medRxiv.
[7] Rommie E. Amaro,et al. SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma , 2021, Proceedings of the National Academy of Sciences.
[8] G. Saberwal,et al. The lag in SARS-CoV-2 genome submissions to GISAID , 2021, Nature Biotechnology.
[9] J. Dennehy,et al. Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater , 2021, Nature Communications.
[10] Gene W. Yeo,et al. Emergence of an early SARS-CoV-2 epidemic in the United States , 2021, Cell.
[11] V. Sintchenko,et al. Genomics-informed responses in the elimination of COVID-19 in Victoria, Australia: an observational, genomic epidemiological study , 2021, The Lancet Public Health.
[12] S. Singh,et al. SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India , 2021, Microorganisms.
[13] Mandev S. Gill,et al. Untangling introductions and persistence in COVID-19 resurgence in Europe , 2021, Nature.
[14] P. Kaleebu,et al. Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda , 2021, Nature Microbiology.
[15] Colin Simpson,et al. Phylodynamics reveals the role of human travel and contact tracing in controlling the first wave of COVID-19 in four island nations , 2021, Virus evolution.
[16] G. Wallau,et al. Identification of SARS-CoV-2 P.1-related lineages in Brazil provides new insights about the mechanisms of emergence of Variants of Concern , 2021 .
[17] William T. Harvey,et al. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 , 2021, Cell Reports.
[18] G. Wallau,et al. COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence , 2021, Nature Medicine.
[19] G. Barton,et al. Effects of common mutations in the SARS-CoV-2 Spike RBD domain and its ligand the human ACE2 receptor on binding affinity and kinetics , 2021, bioRxiv.
[20] M. von Kleist,et al. Rapid incidence estimation from SARS-CoV-2 genomes reveals decreased case detection in Europe during summer 2020 , 2021, Nature Communications.
[21] Matthew T. Maurano,et al. Dispersal dynamics of SARS-CoV-2 lineages during the first epidemic wave in New York City , 2021, PLoS pathogens.
[22] Ravindra K. Gupta. Will SARS-CoV-2 variants of concern affect the promise of vaccines? , 2021, Nature Reviews Immunology.
[23] C. Donnelly,et al. Genetic evidence for the association between COVID-19 epidemic severity and timing of non-pharmaceutical interventions , 2021, Nature Communications.
[24] Gene W. Yeo,et al. Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States , 2021, Cell.
[25] Graham W. Taylor,et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England , 2021, Nature.
[26] S. Duchêne,et al. Development of Phylodynamic Methods for Bacterial Pathogens. , 2021, Trends in microbiology.
[27] William T. Harvey,et al. Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies , 2021, Nature.
[28] Sergei L. Kosakovsky Pond,et al. Detection of a SARS-CoV-2 variant of concern in South Africa , 2021, Nature.
[29] D. Ho,et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 , 2021, Nature.
[30] R. Lanfear,et al. Want to track pandemic variants faster? Fix the bioinformatics bottleneck , 2021, Nature.
[31] D. Stuart,et al. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera , 2021, Cell.
[32] M. Giovanetti,et al. Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil , 2021, Emerging infectious diseases.
[33] Richard van Noorden. Scientists call for fully open sharing of coronavirus genome data , 2021, Nature.
[34] W. Fischer,et al. Recombination and low-diversity confound homoplasy-based methods to detect the effect of SARS-CoV-2 mutations on viral transmissibility , 2021, bioRxiv.
[35] M. Montecino,et al. SARS-CoV-2 infection in asymptomatic healthcare workers at a clinic in Chile , 2021, PloS one.
[36] Genomic epidemiology of the early stages of the SARS-CoV-2 outbreak in Russia , 2021, Nature communications.
[37] D. Ho,et al. Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 , 2021, bioRxiv.
[38] Nuno R. Faria,et al. Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020 , 2021, Emerging infectious diseases.
[39] Jie-Li Hu,et al. Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies , 2021, Cellular & Molecular Immunology.
[40] M. N. Kim,et al. Epidemiologic Linkage of COVID-19 Outbreaks at Two University-affiliated Hospitals in the Seoul Metropolitan Area in March 2020 , 2021, Journal of Korean medical science.
[41] E. Callaway. ‘A bloody mess’: Confusion reigns over naming of new COVID variants , 2021, Nature.
[42] Colin Simpson,et al. Genomic Evidence of In-Flight Transmission of SARS-CoV-2 Despite Predeparture Testing , 2021, Emerging Infectious Diseases.
[43] A. Tanuri,et al. Genomic Characterization of a Novel SARS-CoV-2 Lineage from Rio de Janeiro, Brazil , 2020, Journal of Virology.
[44] Joshua B. Singer,et al. Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland , 2020, Nature Microbiology.
[45] Y. Furuse. Genomic sequencing effort for SARS-CoV-2 by country during the pandemic , 2020, International Journal of Infectious Diseases.
[46] Melis N. Anahtar,et al. Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events , 2020, Science.
[47] K. V. Parag,et al. Establishment & lineage dynamics of the SARS-CoV-2 epidemic in the UK , 2020, medRxiv.
[48] D. A. Jackson,et al. Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity , 2020, Cell.
[49] T. Vaughan,et al. The origin and early spread of SARS-CoV-2 in Europe , 2020, Proceedings of the National Academy of Sciences.
[50] Eric P. Nawrocki,et al. Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research , 2020, Briefings Bioinform..
[51] OUP accepted manuscript , 2021, Virus Evolution.
[52] Nuno R. Faria,et al. Genomic characterisation of an emergent SARS- CoV-2 lineage in Manaus: preliminary findings , 2021 .
[53] A. Godzik,et al. Detection of a SARS-CoV-2 variant of concern in South Africa , 2021, Nature.
[54] Genomic sequencing of SARS-CoV-2 , 2021 .
[55] William L. Hamilton,et al. Patterns of within-host genetic diversity in SARS-CoV-2 , 2020, bioRxiv.
[56] B. Cavadas,et al. Dynamics of a dual SARS-CoV-2 strain co-infection on a prolonged viral shedding COVID-19 case: insights into clinical severity and disease duration , 2020, medRxiv.
[57] F. Balloux,et al. No detectable signal for ongoing genetic recombination in SARS-CoV-2 , 2020, bioRxiv.
[58] Wendy Lu,et al. Timely intervention and control of a novel coronavirus (COVID-19) outbreak at a large skilled nursing facility—San Francisco, California, 2020 , 2020, Infection Control & Hospital Epidemiology.
[59] Paolo Calistri,et al. Genomic Epidemiology of the First Wave of SARS-CoV-2 in Italy , 2020, Viruses.
[60] Santiago Justo Arévalo,et al. Analysis of the Dynamics and Distribution of SARS-CoV-2 Mutations and its Possible Structural and Functional Implications , 2020, bioRxiv.
[61] Lisa E. Gralinski,et al. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo , 2020, Science.
[62] M. Schuld,et al. Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report , 2020, International Journal of Infectious Diseases.
[63] Mandev S. Gill,et al. Epidemiological hypothesis testing using a phylogeographic and phylodynamic framework , 2020, Nature Communications.
[64] A. Pain,et al. Host-directed editing of the SARS-CoV-2 genome , 2020, Biochemical and Biophysical Research Communications.
[65] Trent M. Prall,et al. Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spread , 2020, Nature Communications.
[66] M. Thomson,et al. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain , 2020, Journal of Virology.
[67] M. Koopmans,et al. Unraveling the Modes of Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During a Nursing Home Outbreak: Looking Beyond the Church Superspreading Event , 2020, Clinical Infectious Diseases.
[68] Ankit Gupta,et al. A skyline birth-death process for inferring the population size from a reconstructed tree with occurrences , 2020, bioRxiv.
[69] A. Tatem,et al. Uncovering two phases of early intercontinental COVID-19 transmission dynamics , 2020, Journal of travel medicine.
[70] L. Parida,et al. A common methodological phylogenomics framework for intra-patient heteroplasmies to infer SARS-CoV-2 sublineages and tumor clones , 2020, BMC Genomics.
[71] J. Sevinsky,et al. Genomic evidence for reinfection with SARS-CoV-2: a case study , 2020, The Lancet Infectious Diseases.
[72] M. Suchard,et al. Accommodating individual travel history and unsampled diversity in Bayesian phylogeographic inference of SARS-CoV-2 , 2020, Nature Communications.
[73] M. Exner,et al. SARS‐CoV‐2 outbreak investigation in a German meat processing plant , 2020, EMBO molecular medicine.
[74] D. Larsen,et al. Tracking COVID-19 with wastewater , 2020, Nature Biotechnology.
[75] Lisa A. Jacobson,et al. Serial Testing for SARS-CoV-2 and Virus Whole Genome Sequencing Inform Infection Risk at Two Skilled Nursing Facilities with COVID-19 Outbreaks — Minnesota, April–June 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[76] L. Poon,et al. In-Flight Transmission of SARS-CoV-2 , 2020, Emerging Infectious Diseases.
[77] H. Sax,et al. Does respiratory co-infection facilitate dispersal of SARS-CoV-2? investigation of a super-spreading event in an open-space office , 2020, Antimicrobial resistance and infection control.
[78] T. Vaughan,et al. Estimates of outbreak-specific SARS-CoV-2 epidemiological parameters from genomic data , 2020, medRxiv.
[79] Trevor Bedford,et al. Cryptic transmission of SARS-CoV-2 in Washington state , 2020, Science.
[80] Joel O. Wertheim,et al. The emergence of SARS-CoV-2 in Europe and North America , 2020, Science.
[81] M. Koopmans,et al. Unravelling the modes of transmission of SARS-CoV-2 during a nursing home outbreak: looking beyond the church super-spread event , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[82] Bethany L. Dearlove,et al. A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants , 2020, Proceedings of the National Academy of Sciences.
[83] G. Boland,et al. The SARS-CoV-2 Spike mutation D614G increases entry fitness across a range of ACE2 levels, directly outcompetes the wild type, and is preferentially incorporated into trimers , 2020, bioRxiv.
[84] Sarah K. Hilton,et al. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding , 2020, Cell.
[85] B. Lina,et al. Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France , 2020, bioRxiv.
[86] Benoit Morel,et al. Phylogenetic Analysis of SARS-CoV-2 Data Is Difficult , 2020, bioRxiv.
[87] Colin Simpson,et al. Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand , 2020, Nature Communications.
[88] Amogelang R. Raphenya,et al. A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-Based Sequencing, Random Hexamers, and Bait Capture , 2020, Viruses.
[89] Darren L. Smith,et al. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[90] B. Wiedenheft,et al. Temporal Detection and Phylogenetic Assessment of SARS-CoV-2 in Municipal Wastewater , 2020, Cell Reports Medicine.
[91] R. Myers,et al. Increased risk of SARS-CoV-2 infection in staff working across different care homes: enhanced CoVID-19 outbreak investigations in London care Homes , 2020, Journal of Infection.
[92] D. Flichman,et al. Phylogenetic analysis of SARS‐CoV‐2 in the first few months since its emergence , 2020, bioRxiv.
[93] F. Giardina,et al. Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy , 2020, Nature Communications.
[94] L. Hurst,et al. Evidence for Strong Mutation Bias toward, and Selection against, U Content in SARS-CoV-2: Implications for Vaccine Design , 2020, Molecular biology and evolution.
[95] Edward C. Holmes,et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology , 2020, Nature Microbiology.
[96] William L. Hamilton,et al. Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study , 2020, The Lancet Infectious Diseases.
[97] J. R. Giles,et al. Sample size calculation for phylogenetic case linkage , 2020, medRxiv.
[98] M. Zazzi,et al. Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic , 2020, medRxiv.
[99] William P. Hanage,et al. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear , 2020, Cell.
[100] A. Rambaut,et al. COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study , 2020, The Lancet Infectious Diseases.
[101] T. Wakita,et al. A Genome Epidemiological Study of SARS-CoV-2 Introduction into Japan , 2020, mSphere.
[102] B. Lina,et al. Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation , 2020, bioRxiv.
[103] S. Rowland-Jones,et al. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus , 2020, Cell.
[104] P. Simmonds,et al. Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories , 2020, mSphere.
[105] Samir Bhatt,et al. Evolution and epidemic spread of SARS-CoV-2 in Brazil , 2020, Science.
[106] S. Otto,et al. On the evolutionary epidemiology of SARS-CoV-2 , 2020, Current Biology.
[107] Jason D. Fernandes,et al. Stability of SARS-CoV-2 phylogenies , 2020, bioRxiv.
[108] Trevor Bedford,et al. Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California , 2020, Science.
[109] S. Bhatt,et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe , 2020, Nature.
[110] J. Lourenco,et al. Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report , 2020, International Journal of Infectious Diseases.
[111] A. Huppert,et al. Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within Israel , 2020, Nature Communications.
[112] F. Balloux,et al. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2 , 2020, Nature Communications.
[113] E. Volz,et al. Emerging phylogenetic structure of the SARS-CoV-2 pandemic , 2020, bioRxiv.
[114] W. Hanage,et al. Phylogenetic interpretation during outbreaks requires caution , 2020, Nature Microbiology.
[115] Mark B. Schultz,et al. Tracking the COVID-19 pandemic in Australia using genomics , 2020, Nature Communications.
[116] Victor M Corman,et al. Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series , 2020, The Lancet Infectious Diseases.
[117] D. Patrick,et al. High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice - Skagit County, Washington, March 2020. , 2020, MMWR. Morbidity and mortality weekly report.
[118] P. Lemey,et al. Temporal signal and the phylodynamic threshold of SARS-CoV-2 , 2020, bioRxiv.
[119] Isaac I. Bogoch,et al. Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States , 2020, Cell.
[120] M. Antoniotti,et al. VERSO: A comprehensive framework for the inference of robust phylogenies and the quantification of intra-host genomic diversity of viral samples , 2020, bioRxiv.
[121] Trevor Bedford,et al. Cryptic transmission of SARS-CoV-2 in Washington state , 2020, Science.
[122] Wenjun Ma,et al. Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China , 2020, Cell.
[123] Takuri Takahashi,et al. Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak , 2020, Proceedings of the National Academy of Sciences.
[124] O. Boyd,et al. Genomic epidemiology of a densely sampled COVID-19 outbreak in China , 2020, medRxiv.
[125] Yang Liu,et al. Secondary attack rate and superspreading events for SARS-CoV-2 , 2020, The Lancet.
[126] V. Corman,et al. Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak Related to a Nightclub, Germany, 2020 , 2020, Emerging infectious diseases.
[127] Kheir M. Al-Kodmany. Preliminary Findings , 2020, The Urban Book Series.
[128] Louis du Plessis,et al. Jointly Inferring the Dynamics of Population Size and Sampling Intensity from Molecular Sequences , 2019, bioRxiv.
[129] E. Holmes,et al. Infectious disease phylodynamics with occurrence data , 2019, bioRxiv.
[130] O. Pybus,et al. Parallel molecular evolution and adaptation in viruses , 2019, Current Opinion in Virology.
[131] David A. Rasmussen,et al. Estimating Epidemic Incidence and Prevalence from Genomic Data , 2018, bioRxiv.
[132] Trevor Bedford,et al. Nextstrain: real-time tracking of pathogen evolution , 2017, bioRxiv.
[133] Richard A Neher,et al. TreeTime: Maximum-likelihood phylodynamic analysis , 2017, bioRxiv.
[134] Hayden C. Metsky,et al. Genomic epidemiology reveals multiple introductions of Zika virus into the United States , 2017, Nature.
[135] Trevor Bedford,et al. Virus genomes reveal factors that spread and sustained the Ebola epidemic , 2017, Nature.
[136] Yuelong Shu,et al. GISAID: Global initiative on sharing all influenza data – from vision to reality , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[137] Paul Kellam,et al. Rapid outbreak sequencing of Ebola virus in Sierra Leone identifies transmission chains linked to sporadic cases , 2016, Virus evolution.
[138] Nicola De Maio,et al. New Routes to Phylogeography: A Bayesian Structured Coalescent Approximation , 2015, PLoS genetics.
[139] Lucie M. Gattepaille,et al. Inferring population size changes with sequence and SNP data: lessons from human bottlenecks , 2013, Heredity.
[140] S. Bonhoeffer,et al. Birth–death skyline plot reveals temporal changes of epidemic spread in HIV and hepatitis C virus (HCV) , 2012, Proceedings of the National Academy of Sciences.
[141] M. Suchard,et al. Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A. , 2012, The Journal of general virology.
[142] B. Preston,et al. Case Series , 2010, Toxicologic pathology.
[143] C. Donati,et al. Phylogeny of the SARS Coronavirus , 2003, Science.
[144] Alexei J Drummond,et al. Estimating mutation parameters, population history and genealogy simultaneously from temporally spaced sequence data. , 2002, Genetics.
[145] Andrew Rambaut,et al. Estimating the rate of molecular evolution: incorporating non-contemporaneous sequences into maximum likelihood phylogenies , 2000, Bioinform..
[146] J. Gerring. A case study , 2011, Technology and Society.